Laskin JJ, 2004, Cancer Treat Rev, 30, 1, 10.1016/j.ctrv.2003.10.002
Mendelsohn J, 2001, Endocr Rel Cancer, 8, 3, 10.1677/erc.0.0080003
Woodburn JR, 1999, Pharmacol Ther, 82, 241, 10.1016/S0163-7258(98)00045-X
Laird AD, 2003, Expert Opin Invest Drugs, 12, 51, 10.1517/13543784.12.1.51
Jonker DJ, 2007, New Engl J Med, 357, 2040, 10.1056/NEJMoa071834
Peeters M, 2008, Aliment Pharmacol Ther, 28, 269, 10.1111/j.1365-2036.2008.03717.x
Waldmann TA, 2003, Nature Med, 9, 269, 10.1038/nm0303-269
10.1080/10408360902937809
10.1016/S0168-3659(02)00352-8
Liu D, 2006, Chin Ger J Clin Oncol, 5, 189, 10.1007/s10330-006-0474-1
Minev BR, 1999, Pharmacol Ther, 81, 121, 10.1016/S0163-7258(98)00039-4
Yip YL, 2001, J Immunol, 166, 5271, 10.4049/jimmunol.166.8.5271
Riemer AB, 2007, Immunol Lett, 113, 1, 10.1016/j.imlet.2007.07.008
10.1517/14712590902870386
10.1007/s12026-009-8120-y
Navari M, 2014, Immunopharmacol Immunotoxicol, 36, 309, 10.3109/08923973.2014.945127
Hardy B, 2005, Vaccine, 23, 4283, 10.1016/j.vaccine.2005.04.009
Li W, 2013, BMC Biotechnol, 13, 77, 10.1186/1472-6750-13-77
Riemer AB, 2005, J Natl Cancer Inst, 97, 1663, 10.1093/jnci/dji373
Brämswig KH, 2007, Clin Cancer Res, 13, 6501, 10.1158/1078-0432.CCR-07-0692
Gao J, 2010, Ann Microbiol, 60, 13, 10.1007/s13213-009-0014-7
Wan Y, 2001, Vaccine, 19, 2918, 10.1016/S0264-410X(00)00561-2
van Houten NE, 2006, Vaccine, 24, 4188, 10.1016/j.vaccine.2006.01.001
Yip YL, 2001, Immunol Lett, 79, 197, 10.1016/S0165-2478(01)00281-4
Burritt JB, 1996, Anal Biochem, 238, 1, 10.1006/abio.1996.0241
Smith GP, 1997, Chem Rev, 97, 391, 10.1021/cr960065d
Duś D, 1985, Arch Immunol Ther Exp, 33, 817
Ramírez BS, 2006, Int J Cancer, 119, 2190, 10.1002/ijc.22085
Hu B, 2005, J Immunother, 28, 236, 10.1097/01.cji.0000161394.11831.3f
Lu Y, 2003, J Immunol, 170, 3162, 10.4049/jimmunol.170.6.3162
Kurzepa A, 2009, Clin Exp Med, 9, 93, 10.1007/s10238-008-0027-8
10.4049/jimmunol.180.6.3719
Fang J, 2005, Vaccine, 23, 4860, 10.1016/j.vaccine.2005.05.024
Dabrowska K, 2004, Anticancer Res, 24, 3991
